yingweiwo

SARS-CoV

SARS-CoV

SARS-CoV related products

Structure Cat No. Product Name CAS No. Product Description
(25S)-Antcin B V76093 (25S)-Antcin B 1312711-71-9 Antcin-B is a potent inhibitor of 3CLPro with high affinity.
(H)S(OMe)-DFR-kbt V121821 (H)S(OMe)-DFR-kbt (H)S(OMe)-DFR-kbt is a potent and selective TMPRSS2 inhibitor with a Ki value of 0.13 nM.
(Rac)-X77 V35118 (Rac)-X77 2144491-78-9 (Rac)-X77 is the racemate of X77.
Antiviral agent 5 V53358 Antiviral agent 5 2698336-82-0 antiviral compound 5 is an intermediate for antiviral active molecules targeting 3C and 3CL proteases like: SARS-CoV-2 Mpro.
AT-9010 triethylamine V29256 AT-9010 triethylamine 2648089-95-4 AT-9010 triethylamine is the triphosphate bioactive metabolite of AT-527 and is a potent inhibitor of NiRAN (a function essential for viral replication).
Azelastine-d3 V129734 Azelastine-d3 758637-88-6 Azelastine-d3 is a deuterium-labeled azelastine.
BBH-4 V129921 BBH-4 BBH-4 is a major protease (MPro) inhibitor of SARS-CoV-2.
Bemnifosbuvir hemisulfate (RG-6422; AT-527) V41681 Bemnifosbuvir hemisulfate (RG-6422; AT-527) 2241337-84-6 Bemnifosbuvir hemisulfate (RG-6422; AT-527), the hemisulfate salt of AT-511, is a guanosine nucleotide prodrug and orally bioactive HCV viral replication inhibitor.
BFC220 V111960 BFC220 143-85-1 BFC220 is a covalent SARS-CoV-2 Mpro inhibitor with an IC50 of 2.77 μM.
C-467929 V105339 C-467929 351891-58-2 C-467929 is a Nsp15 endoribonuclease inhibitor with IC50 of 8 μM.
DMA-155 V134007 DMA-155 2237925-69-6 DMA-155 is an antiviral agent that binds to the 5' stem-circular RNA of SARS-CoV-2 with affinities of 51.1 μM (SL1), 61.1 μM (SL4), 54.5 μM (SL5a), 66.9 μM (SL5b), and 48.6 μM (SL6).
EIDD-1931(β-d-N4-羟基胞苷;NHC) V39191 EIDD-1931 (Beta-d-N4-hydroxycytidine; NHC) 3258-02-4 EIDD-1931(EIDD1931; Beta-d-N4-hydroxycytidine; NHC) is anovel and potentribonucleoside analog with antiviral activity.
Enuzovimab V91726 Enuzovimab 2531098-91-4 Enuzovimab is a humanized IgG4 κ monoclonal antibody against SARS-CoV-2.
GRL-1720 V52043 GRL-1720 2835511-03-8 GRL-1720 is a potent SARS-CoV-2 Mpro inhibitor (antagonist) with EC50 of 15 µM.
Imiquimod-d6 (R 837-d6) V80220 Imiquimod-d6 (R 837-d6) Imiquimod-d6 is the deuterium labelled form of Imiquimod.
K22 V138333 K22 2141978-86-9 K22 is an anti-coronavirus compound.
Nirmatrelvir-d6 V141373 Nirmatrelvir-d6 2861202-75-5 Nirmatrelvir-d6 is a deuterium-labeled nirmatrelvir.
NQK-A8 peptide V106194 NQK-A8 peptide The NQK-A8 peptide is an immunodominant peptide of the seasonal coronaviruses HKU1-CoV and OC43-CoV.
P315V3 V106311 P315V3 P315V3 is a pan-coronavirus inhibitor that inhibits SARS-CoV-2 prototype PT, Delta, BA.1, and BA.4 strains with IC50 of 10.9, 8.9, 8.6, and 2.7 nM, respectively.
PF-00835231 (PF-835231) V41524 PF-00835231 (PF-835231) 870153-29-0 PF-00835231 (PF-835231) is a potent 3CLpro [main protease (Mpro)] inhibitor developed by Pfizer for COVID-19treatment.
Contact Us